Hospital
Magee Benevolent Association
Magee Benevolent Association was paid $8.13M by Medicaid between Jan 2018 and Dec 2024, across 128 billing codes. Its largest line is 99283, emergency room visit (moderate) — 25% of everything it billed.
33Billing provider infoMAGEE BENEVOLENT ASSOCIATION
MAGEE, MS 39111
MAGEE, MS 39111
33aNPI1679553994assigned 01/20/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.13M
24GClaims286,100
24DCodes billed128
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Mississippi
Rank by total paid#40 of 77
Median peer was paid$8.23M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 35,521 | $836K | |
| 2019 | 31,121 | $838K | |
| 2020 | 30,953 | $823K | |
| 2021 | 40,265 | $1.29M | |
| 2022 | 49,048 | $1.46M | |
| 2023 | 56,655 | $1.61M | |
| 2024incomplete | 42,537 | $1.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 16,165 | 12,959 | $2.01M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 9.3% | 18,031 | 2,534 | $755K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.8% | 10,300 | 8,038 | $634K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.9% | 4,396 | 3,377 | $558K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.9% | 1,444 | 1,106 | $319K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.9% | 3,481 | 2,731 | $314K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.4% | 9,391 | 7,488 | $278K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.5% | 7,940 | 5,836 | $204K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.4% | 5,809 | 924 | $192K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.2% | 5,448 | 3,806 | $177K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.0% | 5,242 | 4,044 | $164K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.8% | 2,417 | 1,914 | $144K |
116 more codes
| 71046 | Radiologic examination, chest; 2 views | 1.7% | 3,914 | $142K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.7% | 1,293 | $136K |
| 80053 | Comprehensive metabolic panel | 1.6% | 18,791 | $127K |
| 71045 | Radiologic examination, chest; single view | 1.5% | 3,929 | $122K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 23,037 | $116K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.4% | 2,209 | $112K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.3% | 2,256 | $102K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.0% | 542 | $84K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 952 | $79K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,597 | $73K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,905 | $64K |
| G0378 | Hospital observation service, per hour | <1% | 382 | $63K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,091 | $58K |
| 74018 | <1% | 1,372 | $54K | |
| 84146 | <1% | 3,644 | $53K | |
| 80074 | <1% | 1,544 | $48K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 520 | $46K |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 826 | $44K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,972 | $43K |
| 36415 | Collection of venous blood by venipuncture | <1% | 19,445 | $39K |
| 87634 | <1% | 773 | $38K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,587 | $38K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,557 | $37K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,470 | $37K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,513 | $29K |
| 73630 | <1% | 707 | $28K | |
| 80061 | Lipid panel | <1% | 3,153 | $26K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 41 | $25K |
| 73130 | <1% | 572 | $24K | |
| 73562 | <1% | 673 | $23K | |
| 73610 | <1% | 575 | $23K | |
| 81001 | <1% | 11,465 | $22K | |
| 83880 | <1% | 1,566 | $22K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 292 | $22K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,218 | $19K |
| 84484 | <1% | 3,652 | $18K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 828 | $18K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 553 | $17K |
| 81025 | <1% | 2,915 | $16K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,134 | $15K |
| 87088 | <1% | 3,010 | $15K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,005 | $15K |
| 84478 | <1% | 3,349 | $15K | |
| 97533 | <1% | 337 | $14K | |
| 80164 | <1% | 1,241 | $13K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 161 | $13K |
| 83690 | <1% | 2,796 | $12K | |
| 82465 | <1% | 3,345 | $11K | |
| D0272 | Bitewings - two radiographic images | <1% | 51 | $10K |
| 73560 | <1% | 356 | $10K | |
| 73030 | <1% | 367 | $10K | |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 117 | $10K |
| 72100 | <1% | 226 | $9K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 55 | $9K |
| 86592 | <1% | 2,301 | $7K | |
| 80305 | <1% | 807 | $7K | |
| 82550 | <1% | 2,237 | $7K | |
| 86703 | <1% | 553 | $7K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 66 | $6K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 406 | $6K |
| 87807 | <1% | 505 | $5K | |
| 11043 | <1% | 27 | $5K | |
| 87186 | <1% | 816 | $5K | |
| 92523 | <1% | 38 | $5K | |
| 82248 | <1% | 1,131 | $4K | |
| 73110 | <1% | 107 | $4K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 115 | $4K |
| 83605 | <1% | 997 | $4K | |
| 83735 | <1% | 1,251 | $4K | |
| 82607 | <1% | 366 | $3K | |
| 84703 | <1% | 476 | $3K | |
| 73502 | <1% | 91 | $2K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 271 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 62 | $2K |
| 80178 | <1% | 264 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,533 | $1K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 19 | $988.70 |
| 82150 | <1% | 250 | $985.17 | |
| 87077 | <1% | 297 | $885.77 | |
| 97597 | <1% | 22 | $838.73 | |
| 82728 | <1% | 96 | $816.83 | |
| 82948 | <1% | 439 | $797.24 | |
| 85610 | <1% | 317 | $777.62 | |
| J3490 | Unclassified drugs | <1% | 836 | $775.53 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,187 | $732.54 |
| 80076 | <1% | 110 | $597.01 | |
| 87040 | <1% | 126 | $480.03 | |
| 82043 | <1% | 210 | $449.47 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 26 | $415.80 |
| 82570 | <1% | 211 | $403.88 | |
| 93971 | <1% | 16 | $375.92 | |
| 84439 | <1% | 50 | $338.64 | |
| A9270 | Non-covered item or service | <1% | 2,075 | $264.78 |
| 85651 | <1% | 113 | $245.81 | |
| 82044 | <1% | 49 | $213.48 | |
| 87070 | <1% | 30 | $207.66 | |
| 85045 | <1% | 65 | $204.62 | |
| 84702 | <1% | 16 | $148.15 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 15 | $123.30 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,259 | $114.64 |
| 85660 | <1% | 32 | $104.16 | |
| 87205 | <1% | 30 | $98.53 | |
| 83540 | <1% | 13 | $58.20 | |
| 86140 | <1% | 14 | $38.32 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,136 | $33.68 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 189 | $21.10 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 101 | $14.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 131 | $7.38 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 34 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 297 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 544 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 107 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 19 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 1,665 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 160 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 429 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCRUMPTON, ALTHEA (C E O)
| Provider | Location | Paid |
|---|---|---|
| Magee Benevolent Association | Taylorsville, MS | $38K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.